{"id":599894,"date":"2019-01-14T04:53:17","date_gmt":"2019-01-14T04:53:17","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/"},"modified":"2019-01-14T04:53:17","modified_gmt":"2019-01-14T04:53:17","slug":"ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/","title":{"rendered":"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt"},"content":{"rendered":"<p><b>Ibnsina to distribute Novartis\u2019 Alcon products in Egypt:<\/b> Ibnsina Pharma will distribute global eye care product manufacturer Novartis\u2019 <a href=\"https:\/\/www.alcon.com\/\">Alcon\u2019s<\/a> products in Egypt, according to <a href=\"https:\/\/ent.news\/2019\/1\/97.pdf\">a company statement (pdf)<\/a>. The newly inked agreement lends further credence to the argument \u201cthat exclusivity is dying in the pharma market,\u201d Ibnsina Co-CEO Omar Abdel Gawad says. As the fastest growing distributor in Egypt, suppliers who want to grow at or above the market growth rate, have to contract with Ibnsina Pharma to achieve their targets.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ibnsina to distribute Novartis\u2019 Alcon products in Egypt: Ibnsina Pharma will distribute global eye care product manufacturer Novartis\u2019 Alcon\u2019s products in Egypt, according to a company statement (pdf). The newly inked agreement lends further credence to the argument \u201cthat exclusivity is dying in the pharma market,\u201d Ibnsina Co-CEO Omar Abdel Gawad says. As the fastest [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,7115,1414,341,427,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-599894","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-healthcare","tag-ibnsina-pharma","tag-novartis","tag-pharma","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"b4edfbac-6a72-4f19-b3c2-151639601e56","is_powered_by":true,"section_story_id":"aa432654-267b-406c-adb4-f74ffd04721b","story_type":"1","photo_url":"","photo_position":"above","related_issue":[599877],"teaser":"","voice_url":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt\" \/>\n<meta property=\"og:description\" content=\"Ibnsina to distribute Novartis\u2019 Alcon products in Egypt: Ibnsina Pharma will distribute global eye care product manufacturer Novartis\u2019 Alcon\u2019s products in Egypt, according to a company statement (pdf). The newly inked agreement lends further credence to the argument \u201cthat exclusivity is dying in the pharma market,\u201d Ibnsina Co-CEO Omar Abdel Gawad says. As the fastest [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2019-01-14T04:53:17+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt\",\"datePublished\":\"2019-01-14T04:53:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/\"},\"wordCount\":93,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"healthcare\",\"Ibnsina Pharma\",\"Novartis\",\"pharma\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/\",\"name\":\"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2019-01-14T04:53:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/","og_locale":"en_US","og_type":"article","og_title":"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt","og_description":"Ibnsina to distribute Novartis\u2019 Alcon products in Egypt: Ibnsina Pharma will distribute global eye care product manufacturer Novartis\u2019 Alcon\u2019s products in Egypt, according to a company statement (pdf). The newly inked agreement lends further credence to the argument \u201cthat exclusivity is dying in the pharma market,\u201d Ibnsina Co-CEO Omar Abdel Gawad says. As the fastest [&hellip;]","og_url":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2019-01-14T04:53:17+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt","datePublished":"2019-01-14T04:53:17+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/"},"wordCount":93,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","healthcare","Ibnsina Pharma","Novartis","pharma","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/","url":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/","name":"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2019-01-14T04:53:17+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2019\/01\/14\/ibnsina-agrees-with-novartis-to-begin-distributing-alcon-products-in-egypt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Ibnsina agrees with Novartis to begin distributing Alcon products in Egypt"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":631605,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/03\/22\/ibnsina-pharma-targets-26-market-share-by-investing-egp-150-200-mn-in-five-years\/","url_meta":{"origin":599894,"position":0},"title":"Ibnsina Pharma targets 26% market share by investing EGP 150-200 mn in five years","author":"enterpriseam admin","date":"22 March 2018","format":false,"excerpt":"INVESTMENT WATCH- Ibnsina Pharma is looking to invest EGP 150-200 mn over the next five years to increase its market share to 26% from a current 19.3%, Managing Director Omar Abdel Gawad tells Al Mal. The new funds would bring the company\u2019s total investments to EGP 700 mn, a target\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":591237,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/12\/01\/ibnsina-signs-import-and-distribution-agreement-with-mundi-pharma\/","url_meta":{"origin":599894,"position":1},"title":"Ibnsina signs import and distribution agreement with Mundi Pharma","author":"enterpriseam admin","date":"1 December 2019","format":false,"excerpt":"Ibnsina Pharma has signed an agreement with US multinational Mundi Pharma to import and distribute their products in Egypt, the company said in a statement (pdf). Mundi\u2019s product range covers six therapeutic areas including oncology, respiratory, ophthalmology, pain, specialty care, and consumer health. Ibnsina expects revenues from the partnership to\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":625314,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/08\/01\/novartis-says-valsartan-meds-in-egypt-are-safe\/","url_meta":{"origin":599894,"position":2},"title":"Novartis says Valsartan meds in Egypt are safe","author":"enterpriseam admin","date":"1 August 2018","format":false,"excerpt":"PSA- Novartis confirms its Valsartan-containing meds in Egypt are safe for consumption: Novartis Pharma said yesterday that none of its Valsartan-containing meds in Egypt were recalled from the market. The pharma producer explained that blood pressure medication containing impure Valsartan, which is being recalled by order of the Health Ministry,\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":600746,"url":"https:\/\/enterpriseam.com\/egypt\/2019\/02\/10\/efg-hermes-ibnsina-pharma-poised-to-capitalize-on-rising-demand\/","url_meta":{"origin":599894,"position":3},"title":"EFG Hermes: Ibnsina Pharma poised to \u201ccapitalize on rising demand\u201d","author":"enterpriseam admin","date":"10 February 2019","format":false,"excerpt":"Ibnsina Pharma poised to \u201ccapitalize on rising demand\u201d -EFG Hermes: Leading frontier and emerging markets investment bank EFG Hermes has initiated coverage on IbnsinaPharma, which it characterizes as \u201cwell-positioned to capture Egypt\u2019s rising \u2026 demand and continue outperforming the market.\u201d EFG Hermes has a \u201cBuy\u201d on Ibnsina with a target\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":635466,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/12\/05\/ibnsina-pharma-prices-ipo-at-egp-5-80-per-share-says-institutional-offering-is-more-than-17x-oversubscribed\/","url_meta":{"origin":599894,"position":4},"title":"Ibnsina Pharma prices IPO at EGP 5.80 per share, says institutional offering is more than 17x oversubscribed","author":"enterpriseam admin","date":"5 December 2017","format":false,"excerpt":"IPO WATCH- Ibnsina Pharma prices IPO at EGP 5.80 per share, says institutional offering is more than 17x oversubscribed: Ibnsina Pharma announced this morning that it has concluded the book-building process and pricing of its institutional offering of c. 229 mn shares as part of its IPO on the Egyptian\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":628049,"url":"https:\/\/enterpriseam.com\/egypt\/2018\/06\/24\/ibnsina-pharma-lays-out-its-case-to-appeal-antitrust-case\/","url_meta":{"origin":599894,"position":5},"title":"Ibnsina Pharma lays out its case to appeal antitrust case","author":"enterpriseam admin","date":"24 June 2018","format":false,"excerpt":"Ibnsina Pharma lays out case in appeal of antitrust case: Ibnsina Pharma has filed documents countering antitrust allegations leveled against the company by the Egyptian Competition Authority (ECA), said company Chairman Mohsin Mahgoub. A Cairo Economic Court had found in March that Ibnsina, along with competitors United Co. for Pharmacists,\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/599894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=599894"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/599894\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/599877"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=599894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=599894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=599894"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=599894"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=599894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}